KRT18 and cancer: We first focused our attention on characterizing the molecular phenotype of the E/M hybrid state by comparing CK18+/β-catenin+/Slug−/Twist1− EOCCs with CK18+/β-catenin+/Slug+/Twist1− E/M hybrid cancer cells (48 h differentiated).